Kuehn Law, PLLC is investigating whether certain officers and directors of EXELIXIS, Inc. breached their fiduciary duties through potential self-dealing. The firm is encouraging long-term shareholders to contact them as they may be entitled to damages and governance reforms. The investigation highlights concerns about corporate governance and shareholder rights. Shareholders are urged to act promptly due to possible time limits for legal action.
Sanofi has published its half-year financial report for the period ending June 30, 2026, available on its website and filed with regulatory authorities in France and the US. The report highlights Sanofi's strong business performance, including double...
Sanofi has published its financial report for the first half of 2026, available on its website and filed with the French financial authority (AMF). The biopharmaceutical company highlights its innovation in R&D and use of AI to drive long-term growth...
Frank Patton and Kimberlee Mott, financial advisors with 45 years of combined experience managing about $150 million in assets, have joined Balmville Wealth Group through LPL Financial. They bring a focus on retirement planning and multigenerational ...
Crescent Biopharma announced its second quarter 2026 financial results, highlighting progress in clinical trials for its cancer therapies, including CR-001, a PD-1 x VEGF bispecific antibody, and ADC candidates CR-002 and CR-003. The company is enrol...
Ferrari reported Q2 2026 net revenues of €1.94 billion, up 8% year-on-year, driven by a richer product mix and increased personalization sales. Operating profit rose 10% to €605 million with a margin of 31.2%, while net profit grew 9% to €463 million...
